Neuromodulation to treat menopause-related conditions
One aspect of the present disclosure relates to a method for treating a menopause-related condition in a subject. One step of the method can include inserting a therapy delivery device into a vessel of the subject. Next, the therapy delivery device can be advanced to a point substantially adjacent a target site of the sympathetic nervous system (SNS) that is associated with the menopause-related condition. The therapy delivery device can then be activated to deliver a therapy signal to the target site of the SNS in an amount and for a time sufficient to effect a change in sympathetic activity in the subject and thereby treat the menopause-related condition.
1. A method for treating a menopause-related condition in a subject, the method comprising the steps of:
receiving a therapy delivery device in a vessel of the subject at a point substantially adjacent a target site of the sympathetic nervous system (SNS) that is associated with the menopause-related condition; and
activating the therapy delivery device, wherein the therapy delivery device is configured to deliver a therapy signal to the target site of the SNS in an amount and for a time sufficient to substantially block sympathetic activity in the subject and thereby treat the menopause-related condition, wherein the menopause-related condition is hot flashes.
2. The method of claim 1 , wherein the target site of the SNS is a cervical ganglion.
3. The method of claim 1 , wherein the therapy delivery device is configured to automatically deliver the therapy signal to the target site of the SNS at a pre-determined frequency and intensity.
4. The method of claim 1 , wherein the activating step comprises inductively coupling the therapy delivery device to a power source.
5. The method of claim 1 , wherein the vessel is one of an intercostal vein, an intercostal artery, or a subclavian artery.
6. A method for treating a menopause-related condition in a subject, the method comprising the steps of:
receiving a therapy delivery device in the subject so that the therapy delivery device is in electrical contact with a target site of the SNS associated with the menopause-related condition; and
activating the therapy delivery device, wherein the therapy delivery device is configured to deliver a therapy signal to the target site of the SNS in an amount and for a time sufficient to substantially block sympathetic activity in the subject and thereby treat the menopause-related condition, wherein the menopause-related condition is hot flashes.
7. The method of claim 6 , wherein the target site of the SNS is a cervical ganglion.
8. The method of claim 6 , wherein the therapy delivery device is configured to automatically deliver the therapy signal to the target site of the SNS at a pre-determined frequency and intensity.
9. The method of claim 6 , wherein the activating step comprises inductively coupling the therapy delivery device to a power source.